Table 1

Percentage of patients (obese and normal weight, each n = 1150) receiving prescriptions from each of the 15 main BNF prescribing categories during the 18-month period.

BNF categoryBMI 18.5–<25 normal weight (n [%])BMI ≥30 obese (n [%])P-valueaP-valueb
Cardiovascular system231 (20.1)415 (36.1)<0.001<0.001
Central nervous system403 (35.0)534 (46.4)<0.001<0.001
Endocrine system206 (17.9)299 (26.0)<0.001<0.001
Musculoskeletal and joint disease248 (21.6)349 (30.3)<0.001<0.001
No prescriptions270 (23.5)184 (16.0)<0.0010.011
Infections402 (35.0)481 (41.8)0.0010.008
Gastrointestinal207 (18.0)273 (23.7)0.0010.025
Skin223 (19.4)281 (24.4)0.0050.033
Respiratory system208 (18.1)250 (21.7)0.0320.392
Ear, nose, oropharynx75 (6.5)100 (8.7)0.0540.090
Obstetrics, gynaecology and urinary tract disorders159 (13.8)189 (16.4)0.0560.136
Anaesthesia2 (0.2)5 (0.4)0.2700.261
Malignant disease and immunosupression12 (1.0)10 (0.9)0.6050.448
Nutrition and blood78 (6.8)74 (6.4)0.6860.361
Vaccines119 (10.3)123 (10.7)0.8780.919
Eye102 (8.9)102 (8.9)0.8960.564
  • a P-value derived from logistic regression model comparing the obese vs normal weight prescribing rates with adjustment for age, sex, deprivation category, and country.

  • b P-value derived from logistic regression model comparing the obese versus normal weight prescribing rates after adjustment for age, sex, deprivation category, country, and the presence of a comorbidity. BNF = British National Formulary.